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etorphine-induced hypoxaemia in chemically
immobilized white rhinoceros (Ceratotherium
simum)
Anna Haw1, Markus Hofmeyr3,2, Andrea Fuller1, Peter Buss3,6, Michele Miller4, Gregory Fleming5 and Leith Meyer1,2*Abstract
Background: Opioid-induced immobilization is associated with severe respiratory depression in the white rhinoceros.
We evaluated the efficacy of butorphanol and oxygen insufflation in alleviating opioid-induced respiratory depression
in eight boma-managed rhinoceros.
Results: Chemical immobilization with etorphine, azaperone and hyaluronidase, as per standard procedure for
the white rhinoceros, caused severe respiratory depression with hypoxaemia (PaO2 = 27 ± 7 mmHg [mean ± SD]),
hypercapnia (PaCO2 = 82 ± 6 mmHg) and acidosis (pH =7.26 ± 0.02) in the control trial at 5 min. Compared to
pre-intervention values, butorphanol administration (without oxygen) improved the PaO2 (60 ± 3 mmHg, F(3,21) =151.9,
p <0.001), PaCO2 (67 ± 4 mmHg, F(3,21) =22.57, p <0.001) and pH (7.31 ± 0.06, F(3,21) =27.60, p <0.001), while oxygen
insufflation alone exacerbated the hypercapnia (123 ± 20 mmHg, F(3,21) =50.13, p <0.001) and acidosis (7.12 ± 0.07,
F(3,21) =110.6, p <0.001). Surprisingly, butorphanol combined with oxygen fully corrected the opioid-induced hypoxaemia
(PaO2 = 155 ± 53 mmHg) and reduced the hypercapnia over the whole immobilization period (p <0.05, areas under
the curves) compared to the control trial. However, this intervention (butorphanol + oxygen) did not have any
effect on the arterial pH.
Conclusions: Oxygen insufflation combined with a single intravenous dose of butorphanol improved the
immobilization quality of boma-managed white rhinoceros by correcting the opioid-induced hypoxaemia, but did
not completely reverse all components of respiratory depression. The efficacy of this intervention in reducing
respiratory depression in field-captured animals remains to be determined.
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Potent opioids, such as etorphine hydrochloride, are
used routinely for the chemical immobilization of white
rhinoceros (Ceratotherium simum), an essential procedure
for the management and conservation of this species.
Whilst these potent mu-agonist opioids induce a rapid
immobilization, respiratory depression characterized by
hypoventilation, hypoxaemia, hypercapnia and acidaemia* Correspondence: Leith.Meyer@up.ac.za
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unless otherwise stated.is common [1-6]. The opioid-induced respiratory depres-
sion also is compounded by rigidity of the animal’s thor-
acic musculature, which impairs respiratory excursions
[4]. Respiratory depression is arguably the most significant
complication in the immobilization and anaesthesia of
white rhinoceros [1,7,8], with animals shown to have an
arterial oxygen partial pressure of less than 40 mmHg [2].
In an effort to reduce the respiratory depression, attempts
have been made to selectively antagonize the undesirable
side-effects of pure-opioid agonists while preserving their
potent analgesic, sedative and catatonic effects, using mixed
opioid agonists-antagonists such as nalorphine [7] and
butorphanol [5,9]. Nalorphine is no longer readily available,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Drug doses for white rhinoceros immobilization
(Buss)
Weight
(kg)
Etorphine
(mg)
Azaperone
(mg)
Butorphanol
(mg)
Naltrexone
(mg)
500-750 1.5 22.5 22.5 30
750-1000 2.0 30.0 30.0 40
1000-1250 2.5 37.5 37.5 50
1250-1500 3.0 45.0 45.0 60
1500-1750 3.5 52.5 52.5 70
1750-2000 4.0 60.0 60.0 80
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However, whether butorphanol effectively reduces respira-
tory depression is not clear from the few studies that have
been done [5,9]. Oxygen administered intranasally [10] or
via nasotracheal intubation [3] also has been used to in-
crease blood oxygen levels in etorphine-immobilized white
rhinoceros, but field practitioners have questioned its effi-
cacy and safety (Buss, personal communication).
In this paper, we critically evaluate combinations of
butorphanol and oxygen insufflation in a controlled boma
(small enclosure used to temporarily hold wild animals)
setting to determine their efficacy in alleviating opioid-
induced respiratory depression in white rhinoceros.
Methods
This project was approved by the Animal Use and Care
Committee, South African National Parks (SANParks) as
well as the Animal Ethics Screening Committee of the
University of the Witwatersrand (clearance 2012/23/04).
Study area and sample population
Eight sub-adult (3–5 year old) male white rhinoceros were
captured within Kruger National Park (−24.98984 S,
31.59263 E, Alt. 317 m) and housed individually in hold-
ing facilities (bomas) according to SANParks’ standard
operating procedures. Food intake (lucerne and hay),
defaecation and general demeanour were assessed daily
for each rhinoceros. The trial started after a one month
adaptation period. Data collection occurred from August
to December 2012 and all immobilizations took place
between 05H20 and 10H50. Black globe temperature
(thermal load) ranged from 10°C to 43°C and barometric
pressure varied from 737.0 to 745.9 mmHg.
Chemical immobilization and experimental design
At each trial, the rhinoceros was immobilized with a
combination of 2–3 mg etorphine hydrochloride (M99®,
Novartis, Kempton Park, South Africa, 9.8 mg/ml),
30–45 mg azaperone (Stressnil®, Janssen Pharmaceutical
Ltd., Halfway House, South Africa, 40 mg/ml), and 2500
i.u. hyaluronidase (lyophilized hyalase, Kyron Laboratories,
South Africa). Drug doses were determined by body mass
(Buss, personal communication, Table 1). Immobilizing
drugs were administered into the nuchal hump using a
3 ml plastic dart with a 60 mm needle, fired with a CO2-
powered dart-gun (Dan-Inject, South Africa). Once safe
to handle the rhinoceros was blindfolded and positioned in
lateral recumbency (Time 0) with padding under the head
to ensure the lower nostril remained patent. Trials were
performed only if the animal became immobile within
15 minutes of darting. Recumbency position was altered
between left and right body side at each immobilization.
The experiment consisted of four trials in which the
interventions butorphanol (15 mg per mg etorphine,Kyron Laboratories, Benrose, South Africa, 20 mg/ml),
butorphanol (15 mg per mg etorphine) + oxygen insuffla-
tion (30 L/min), oxygen insufflation (30 L/min) on its
own, and sterile water (control) were evaluated and com-
pared as measures to support the respiratory physiology of
the immobilized white rhinoceros. Each rhinoceros re-
ceived each intervention for the four trials in a rando-
mised order at two-week intervals. The interventions were
administered 6 min after the rhinoceros became laterally
recumbent. Clinical data and samples were collected at
5 min after animals became laterally recumbent (before
the intervention) and every 5 minutes thereafter for a
20-minute immobilization period. In the two trials
where butorphanol was not administered at 6 min (oxygen
only and control interventions), butorphanol (15 mg per
mg etorphine) was administered at 21 minutes to facilitate
arousal and loading into a crate.
Clinical monitoring and data collection
Respiratory rate was monitored by an observer counting
thoracic and abdominal excursions and feeling for ex-
pired air at the nares. The level of immobilization was
assessed by observing body and ear movements at 5, 10,
15 and 20 min. The level of immobilization score ranged
from 1 (no immobilizing or sedative effect) to 6 (excessive
immobilization depth with respiration <3 breaths/min).
Level 3 indicated a safe standing sedation, while levels 4
and 5 indicated recumbent immobilization with or with-
out ear movement, respectively.
Arterial blood samples for blood gas analysis were col-
lected from the medial auricular artery catheterized with
a 22G × 1” IV catheter (Nipro Safelet Cath, Nipro Corpor-
ation) and secured in place with superglue (SuperGlue,
Loctite®). A 0.5 ml sample was collected anaerobically into
1 ml heparinised syringes at 5, 10, 15 and 20 minutes after
the rhinoceros became laterally recumbent. A final arterial
sample was taken in the standing sedated rhinoceros, once
positioned in a crate for weighing, 23 to 33 minutes after
initial lateral recumbency. Arterial pH, partial pressures of
carbon dioxide (PaCO2), and oxygen (PaO2), and haemo-
globin oxygen saturation (SaO2, data not shown) were
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portable precalibrated blood gas analyzer with precalibrated
blood gas cassettes (Roche OPTI CCA Analyzer +OPTI
cassette B, Kat Medical, Johannesburg, South Africa). The
blood gas analyzer could not measure SaO2 values below
60%. The catheter was maintained with a heparinised
(Heparin 5000 i.u./ml; Fresenius, Port Elizabeth, South
Africa) saline flush and 1–2 ml of blood was discarded
before collection of each sample.
During the experiments in which oxygen was delivered,
nasotracheal intubation was achieved using an equine
stomach tube (9.5 mm od × 213 cm, Kyron Laboratories)
as described by Bush and colleagues [3]. Tracheal intub-
ation was verified by hearing the air pass through the tube
during respiration. Oxygen was delivered at a constant
flow rate of 30 L/min based on earlier reports [3,4] and a
prior pilot study.
Twenty-one minutes into the recumbent period, the
rhinoceros was stimulated to stand and was guided into
a crate for weighing. The quality of arousal was assessed
according to the amount of stimulation needed to get
the animal into a standing position and ability to guide
the animal into a crate using an interval scale from 1 to
5. One indicates that the animal gets up too quickly, is
too awake and cannot be blindfolded. 2 and 3 indicate that
the animal gets up and can be safely handled and walked,
with minor (2) or moderate (3) stimulation. 4 indicates
that excessive stimulation is needed to get the animal
standing and walking, while 5 indicates that the animal
struggles to get up even after excessive stimulation and is
unable to walk.
Approximately 35 min after the animals became lat-
erally recumbent, the effects of etorphine were reversed
using naltrexone (50 mg/ml, Kyron Laboratories, South
Africa) administered intravenously into an auricular vein
at 20-times the etorphine dose. The animals were then
released from the crate into their bomas. The quality of
recovery was subjectively categorized as poor, average or
good by an individual veterinarian.
All rhinoceros used in these trials were monitored
using a standardized boma scoring system on a daily
basis for changes in appetite, defaecation, and behaviour.
In addition, haematological and biochemical analyses
were performed at the time of each immobilization to
assess any changes in health status.
Data analysis
Statistical analyses were performed using GraphPad
Prism version 4.00 for Windows (GraphPad Software,
San Diego, California, USA). All results are expressed as
means ± SD, and statistical differences with p <0.05 were
considered significant. For PaO2, PaCO2, pH and respira-
tory rate, a repeated measures two-way analysis of vari-
ance (ANOVA) followed by Bonferroni post-tests wasused to test for differences between responses to butor-
phanol, butorphanol + oxygen, oxygen, and sterile water
(control) at 5, 10, 15 and 20 min and between time
points for each intervention. To determine the inte-
grated response over time, areas under the response
curves to butorphanol, butorphanol + oxygen, oxygen and
sterile water (control) were calculated for these same
variables (PaO2, PaCO2, pH and respiratory rate) for the
period during lateral recumbency. A one-way ANOVA
followed by a Student-Newman-Keuls (SNK) post hoc test
was used to test for differences between these areas. The
measurements taken while the animals were standing
in the crate were analysed separately with a one-way
ANOVA followed by a SNK post hoc test to compare
differences between the trials in the standing rhinoceros.
Results
All rhinoceros were in good health and showed behaviour
indicative of healthy boma-managed rhinoceros through-
out the trial. Although, initially after being relocated to
the boma, the animals lost weight, they gained body mass
gradually over time (average gain of 16 kg during the final
two-week interval). The initial weight loss, associated with
a brief period of anorexia, normally occurs while the ani-
mals adapt to captivity. Results of serum biochemical and
haematological analyses were considered within normal
ranges for healthy white rhinoceros [11]; Miller, personal
communication. Follow-up monitoring of other health
parameters subsequent to the experiment indicated no
change in health status.
Immobilization
The administration of etorphine (0.002 mg/kg), azaperone
(0.03 mg/kg) and hyaluronidase (2500 i.u) led to rapid
immobilization of rhinoceros (5 ± 1 minutes) after darting.
There was no difference in time to recumbency between
the four different trials (control, butorphanol, butorpha-
nol + oxygen and oxygen) (F(3,28) =0.95, p =0.43). The level
of immobilization of the rhinoceros also did not differ sig-
nificantly between different trials. When recumbent, the
rhinoceros were usually relaxed with some ear movements
(median immobilization level 4); occasionally they would
enter a deeper state of immobilization where they would
be fully relaxed without any ear movement (level 5).
Respiratory rate
Immobilization with etorphine, azaperone and hyal-
uronidase caused hypopnea (7 ± 2 breaths/min; nor-
mal mean [±SD] =19 [±0.6], breaths/min, [12]) which
persisted throughout the immobilization period in an-
imals that received the control (sterile water). There
was no statistical difference (F(3,28) =6.03, p >0.05) in
mean respiratory rates between trials at t =5 min
(butorphanol =6 ± 1; butorphanol + oxygen =7 ± 1;
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respiratory rate in the butorphanol trial significantly
(F(3,21) =48.30, p <0.001) increased following butorphanol
administration to 10 breaths/min (SD 1) at t =10, this
change was not different than mean respiratory rate
for the control intervention (7 ± 2 breaths/min, t =10;
p >0.05) (Figure 1A). However, when comparing the
overall response over the immobilization period by
comparing areas under the response curves (Figure 2A)
respiratory rate did increase with butorphanol admin-
istration (p <0.05). Similarly, butorphanol combined
with oxygen caused an initial increase in respiratory
rate (9 ± 2 breaths per min at 10 min; F(3,21) =8.97,
p <0.01). However, this improvement was not sustained
and the respiratory rate over the full 20-min immobilization
period was not different from the control trial (Figure 2A).
Oxygen insufflation as sole support caused a decrease in
respiratory rate at 10, 15 and 20 min, compared to
5 min (F(3,21) =37.62, p <0.001), and resulted in an overall
lower respiratory rate than in the control trial (p <0.001,
Figure 2A).Figure 1 Values are respiratory rate (A), partial pressure of arterial ca
(PaO2) (C), and arterial pH (D) (means, SD, n =8) of rhinoceros given i
insufflation, oxygen insufflation and intravenous sterile water (contr
Arrow at 6 minutes indicates time at which the intervention was given. Ar
lines indicate average normal values in standing, unsedated white rhinoce
other with letters indicating the treatment comparisons as follows: a = bu
c = butorphanol vs. oxygen; d = oxygen vs. control; e = oxygen vs. butorphPartial pressure of arterial carbon dioxide (PaCO2)
The decrease in respiratory rate induced by chemical
immobilization resulted in severe hypoventilation, as in-
dicated by the extreme hypercapnia (82 ± 6 mmHg, nor-
mal =49 [±0.9] mmHg [12]) at 5 min in the control trial,
which did not change over time (F(3,21) =2.68, p =0.073).
The initial hypercapnia at 5 min was similar across
rhinoceros in all trials (butorphanol =83 ± 9 mmHg;
butorphanol + oxygen =79 ± 7 mmHg; oxygen =82 ±
8 mmHg) (Figure 1B). Butorphanol administration led to
a decrease in PaCO2 from 5 to 10 min (67 ± 4 mmHg,
p <0.001) which resulted in an overall improvement
compared to the control (p <0.001, areas under the re-
sponse curves, Figure 2B). The administration of butor-
phanol + oxygen did not result in an improvement in
PaCO2 levels at 10, 15 or 20 min, compared to pre-
intervention values (F(3,21) =1.31, p >0.05, PaCO2 = 72 ±
13 mmHg at 20 min). However, over the full 20-min
immobilization period, the PaCO2 was lower (p <0.05,
areas under the response curves, Figure 2B) than that of
the control. Oxygen insufflation as sole support had anrbon dioxide (PaCO2) (B), partial pressure of arterial oxygen
ntravenous butorphanol, intravenous butorphanol + oxygen
ol) 6 minutes after the rhinoceros became laterally recumbent.
row at 21 minutes indicates the end of lateral recumbency. Dotted
ros [12]. The brackets show when treatments differed from each
torphanol vs. control; b = butorphanol vs. butorphanol + oxygen;
anol + oxygen and f = butorphanol + oxygen vs. control.
Figure 2 Areas under the response curves. Comparisons between the calculated values of the area under the response curves for respiratory
rate (A), partial pressure of arterial carbon dioxide (PaCO2) (B), partial pressure of arterial oxygen (PaO2) (C) and arterial pH (D). The asterix (*) indicates
when the treatments butorphanol (But), butorphanol + oxygen (But + O2) or oxygen only (O2) differ significantly from the control, with the number of
asterixes indicating the level of significance (*p <0.05, **p <0.01 and ***p <0.001).
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to 106 ± 21 mmHg (F(3,21) =50.13, p <0.001). At 15 min,
PaCO2 peaked at 123 ± 20 mmHg, about 50% higher
than the control value (p <0.001) at that time point
(Figure 1B).
Partial pressure of arterial oxygen (PaO2)
Chemical immobilization resulted in severe hypoxaemia
(PaO2 = 27 ± 1 mmHg, normal =98.2 [±1.4] mmHg [12])
in the control trial at 5 min. This hypoxaemia at
5 min was similar across rhinoceros in all trials
(butorphanol =28 ± 4 mmHg; butorphanol + oxygen =31 ±
6 mmHg; oxygen =30 ± 7 mmHg) (Figure 1C). Without
any supportive treatment, oxygenation remained at ex-
tremely low levels (less than 35 mmHg) throughout the
immobilization period. Butorphanol administration resulted
in an immediate increase in PaO2 (60 ± 3 mmHg at 10 min;
F(3,21) =151.9, p <0.001), with better oxygenation compared
to the control over the whole immobilization period
(p <0.05, areas under the response curves, Figure 2C),
although normoxia was not attained. Butorphanol +
oxygen resulted in a marked and sustained increase in
PaO2 (99 ± 26 mmHg at 10 min, F(3,21) =33.36, p <0.001),
which was greater than the control value at all time points
(p <0.001) (Figure 1C). Indeed, butorphanol + oxygen
increased PaO2 to levels above those normally seen in
standing, unsedated white rhinoceros, and the in-
crease was greater than butorphanol administrationalone (butorphanol + oxygen =154 ± 53 mmHg; butor-
phanol =54 ± 4 mmHg at 20 min, p <0.001). Surpris-
ingly, the overall improvement in PaO2 was greater
than the combined effects of butorphanol alone and
oxygen alone (Figure 2C). Administration of oxygen alone
resulted in a delayed increase in PaO2 with an improvement
seen only at 15 and 20 min (54 ± 17 mmHg, F(3,21) =7.82,
p <0.05) compared to pre-intervention values. However,
oxygen insufflation did not result in an overall improve-
ment in PaO2 compared to the control (p >0.05, areas
under the response curves, Figure 2C).
Arterial pH
Corresponding to the severe hypercapnia, animals that
received the control intervention were acidaemic at
5 min (pH =7.26 ± 0.02, normal =7.39 ± 0.1 [12]) and
their pH remained low throughout the immobilization
period, with no difference between the pH at 5 min
(7.26 ± 0.02) and 20 min (7.24 ± 0.05, F(3,21) =4.64,
p >0.05). The initial acidaemia at 5 min was similar
across all treatment groups (butorphanol =7.27 ± 0.04;
butorphanol + oxygen =7.28 ± 0.04; oxygen =7.25 ± 0.04)
(Figure 1D). When butorphanol was administered, arterial
pH improved initially, with pH at 10 min (7.31 ± 0.06)
higher (p <0.001) than the pre-intervention pH. However,
this improvement was not sustained and the rhinoceros
remained acidaemic throughout the immobilization
period. Overall, butorphanol led to an improvement in
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sponse curves, Figure 2D). Butorphanol + oxygen did not
alter the pH at any time points following the intervention
(F(3,21) =0.55, p =0.66) and over the full 20-min
immobilization period, the pH was not different from
the control (Figure 2D). Oxygen alone caused a drop in
pH from 7.25 ± 0.04 at 5 min to 7.13 ± 0.03 at 20 min
(F(3,21) =110.5, p <0.001), resulting in more severe acidae-
mia compared to the control and all other interventions
(p <0.001, areas under the response curves, Figure 2D).
Arousal
The median arousal score for rhinoceros after immobilization
with butorphanol was 2, (animal gets up easily after
minor stimulation, and when standing can be blindfolded,
safely handled and walked without stimulation); while
that for the control, oxygen and butorphanol + oxygen
was 3 (animal gets up after moderate stimulation and
when standing can be blindfolded, safely handled and
walked with stimulation). Thus, rhinoceros that received
only butorphanol at 6 min were aroused more easily at
26 min compared to rhinoceros that received the other
treatments. Following the full reversal with naltrexone, all
rhinoceros had a good or average recovery and returned
to their bomas without complication.
Arterial blood results from standing sedated rhinoceros
The last blood sample from the standing sedated
rhinoceros while in the weighing crate, was taken, on aver-
age, 27 min (range 23–33 min) after the rhinoceros became
recumbent. Following all the interventions, including the
control, samples from the standing sedated rhinoceros indi-
cated that the animals were still hypoxaemic (mean PaO2
values: control =69 ± 3mmHg, butorphanol =58 ± 9mmHg,
butorphanol + oxygen =64 ± 8 mmHg, oxygen =87 ±
9 mmHg), hypercapnic (mean PaCO2 values: control =64 ±
4 mmHg, butorphanol =67 ± 3 mmHg, butorphanol + oxy-
gen =67 ± 5 mmHg, oxygen =58 ± 4 mmHg) and acidaemic
(mean pH values: control =7.33 ± 0.05, butorphanol =7.34
± 0.03, butorphanol + oxygen =7.33 ± 0.02, oxygen =7.37 ±
0.05). However, the PaO2 values (87 ± 9 mmHg) from the
animals that had received oxygen during immobilization,
and then butorphanol one minute before walking, were
higher than those in the butorphanol + oxygen (p <0.05)
and butorphanol (p <0.01) groups.
Discussion
We have shown that butorphanol administration in recently
immobilized white rhinoceros attenuates the respiratory
derangements that typically occur after etorphine-induced
immobilization. However, the animals were still critically
hypoxaemic (PaO2 = 53 ± 4 mmHg, normal PaO2 = 98.2 ±
1.4 mmHg [12]) 20 minutes into the immobilization
period. The drug-induced hypoxaemia in white rhinoceros,however, could be corrected completely by administering
intravenous butorphanol shortly after recumbency and
supplying oxygen throughout the immobilization period
via nasotracheal intubation. As far as we are aware, this is
the first report of a protocol to completely reverse the
severe hypoxaemia associated with etorphine-induced
immobilization in white rhinoceros. However, the animals
remained hypercapnic and acidaemic, illustrating that the
immobilization-induced respiratory derangements were
not entirely corrected. Surprisingly, we found that oxygen
administered directly into the trachea at a flow rate of
30 L/min as sole support, decreased respiratory rate and
exacerbated hypercapnia. Moreover, partial pressure of
arterial oxygen was not statistically different from that of
rhinoceros in the control group.
Arterial blood gas analysis is the gold standard for
assessing the adequacy of oxygenation and ventilation.
Although PaO2 and PaCO2 could be accurately deter-
mined, due to equipment logistics (uncuffed oxygen ad-
ministration tubing), measurement of fractional inspired
oxygen (FiO2) during oxygen interventions would have
been inaccurate due to mixing of air with delivered oxy-
gen. Therefore, the alveolar-arterial pressure gradient
(P(A-a)O2) and other calculations could not be performed.
To our knowledge, this crossover trial is the first to crit-
ically evaluate, in a controlled environment, the respira-
tory physiology of the white rhinoceros during chemical
immobilization. The effects of butorphanol [5,9] and oxy-
gen insufflation [3] have been assessed previously during
field immobilizations. However, as a result of uncontrolled
variables (for example, dart placement, animal exertion)
that occur in field trials, it is often difficult to establish de-
finitive efficacy of a treatment, and comparing data from
different field studies is thwart with error. Nevertheless,
our study supports the common finding that etorphine
immobilization in the white rhinoceros results in severe
hypoxaemia together with hypercapnia and acidosis
[1-3,5,7]. This hypoxaemia may be even more severe
than previously reported, with rhinoceros sometimes
having PaO2 values below 25 mmHg, less than a quarter
of the normal value in an awake animal, five minutes
into the immobilization period. Previously, the lowest
reported PaO2 values were between 30 – 40 mmHg [2,3,5].
These negative effects of etorphine-induced immobilization
on respiratory function are consistent with etorphine’s
action as a potent mu-opioid receptor agonist.
Butorphanol is a mixed opioid agonist–antagonist,
which has either mu-antagonist or partial mu-agonist and
kappa-agonist activity [13]. Use in white rhinoceros
immobilization is based on anecdotal evidence that butor-
phanol improves respiration by reversing the etorphine-
induced mu-receptor activation [8]. However, Miller and
colleagues [9] recently suggested that the beneficial
effect of butorphanol may be related to a change in
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mu-receptors. Their conclusion was based on the per-
sistence of hypoxaemia in rhinoceros given butorphanol
during field immobilizations. In another study, immobi-
lized white rhinoceros given nalorphine and diprenor-
phine, two other mixed opioid agonists-antagonists, also
remained markedly hypoxaemic during immobilization
[10]. Our finding that rhinoceros that received butorpha-
nol 6 min after lateral recumbency were still hypoxaemic
after 20 minutes of immobilization supports the idea that
butorphanol does not reverse opioid-induced respiratory
depression. However, in the rhinoceros in this study, ven-
tilation did improve after butorphanol administration in
comparison to the control, as indicated by lower PaCO2
and an improvement in PaO2. According to our ‘level of
immobilization score’, butorphanol did not induce a lighter
plane of immobilization compared to the control; how-
ever, we observed that some animals, although they
remained completely immobile, were more responsive to
gentle manipulation of the ear with this treatment. In
future, additional criteria, such as response to a tactile
stimulus, should be included in the ‘level of immobilization’
score. Butorphanol also appeared to reduce the etorphine-
induced muscle tension and chest rigidity, an effect that
may have accounted for improved minute ventilation.
In addition to butorphanol, another available treat-
ment that has been advanced for improving oxygenation
during rhinoceros immobilization is oxygen insufflation.
In one study [3], the use of oxygen insufflation in field-
immobilized white rhinoceros significantly increased
arterial oxygen concentrations. Unexpectedly, our study
contradicts these findings as we showed that oxygen as
sole support did not improve PaO2 values compared to
the control, and indeed had a detrimental effect on the
respiratory status of immobilized white rhinoceros. This
disparity in findings may be a result of intermittent use
of a partial-opioid antagonist (nalorphine) and a respiratory
stimulant (doxapram) during the field-based study [3], and
other confounding variables associated with field trials.
Despite the variability between these studies, it is evi-
dent that hypoventilation, indicated by an increase in
PaCO2, contributes to hypoxaemia in immobilized white
rhinoceros. Another major contributing factor is likely
to be ventilation-perfusion mismatch [1,5,10]. Previous
studies have shown that P(A-a)O2 values in immobilized,
recumbent white rhinoceros are often high [5]. More-
over, atelectasis has been found to occur after prolonged
immobilization and recumbency in a white rhinoceros [1],
and intrapulmonary shunts are a well-described complica-
tion of anaesthesia and recumbency in another large per-
issodactyl, the horse [14,15]. Together with intrapulmonary
shunts, lateral recumbency in large quadrapeds leads to
ventilation of under-perfused alveoli resulting in increased
alveolar dead space. Indeed, in black rhinoceros, alveolardead space was found to be greater in lateral, compared to
sternally recumbent black rhinoceros [16]. Recumbency
therefore most likely played an important role in the re-
spiratory derangements of the rhinoceros in our study, but
was not the primary cause of respiratory depression. We
believe the primary cause was opioid-induced respiratory
depression as the animal’s ventilatory response was inad-
equate to this severe hypoxaemia and hypercapnia.
The massive size of the rhinoceros undoubtedly con-
tributes to atelectasis on the dependent side of the lung
regions in laterally recumbent animals. However, absorp-
tion atelectasis, which occurs when less gas enters the
alveolus than is removed by uptake by the blood, may be
influenced by other factors such as gas composition [17].
The rate of absorption of gas from the alveoli into the
blood increases with increasing FiO2 as oxygen is absorbed
more quickly than nitrogen [17]. In humans with acute re-
spiratory failure, mechanical ventilation with 100% oxygen
causes an increase in intrapulmonary shunting primarily
as a result of absorption atelectasis resulting from alveolar
denitrogenation and pulmonary vasodilatation in unventil-
ated lung areas [18-20]. Similarly, in horses under general
anaesthesia where airway integrity is compromised by the
weight of abdominal organs, increased intrapulmonary
shunting occurs as a result of atelectasis when breathing
high FiO2 (>0.8) compared to a lower FiO2 (0.21-0.3)
[21,22]. It has also been demonstrated in horses receiving
supplemental oxygen that lower minute ventilation will
result in higher FiO2 [23]. Thus we propose that the
rhinoceros receiving oxygen supplementation in our study
had a high FiO2 together with narrowed or compressed
airways as a result of pressure from abdominal organs and
poor ventilation. In rhinoceros administered oxygen, gases
in the alveoli were likely absorbed faster than they could
be replaced and atelectasis ensued. If atelectasis is severe
enough to cause shunt fractions in excess of 50%, oxygen
supplementation will not be effective [10]. Therefore, we
suggest that the rhinoceros receiving oxygen as the only
intervention had significant intra-pulmonary shunt frac-
tions, probably in the region of 50% or greater, as their
PaO2 values were not significantly greater than the control.
When butorphanol was combined with oxygen insuf-
flation, the partial pressure of arterial oxygen was sub-
stantially improved, and indeed entirely corrected with
PaO2 reaching 154 ± 53 mmHg by the end of the recum-
bent period. This marked effect is difficult to explain given
the negative effects of oxygen on its own, and the moder-
ate improvements seen with butorphanol alone, but is
most likely a result of the improved tidal volume and chest
expansion induced by the butorphanol, which facilitated
the high concentration of oxygen in the alveoli to dissolve
into the blood without causing excessive atelectasis.
If atelectasis occurred in the rhinoceros that received
oxygen only, it must have resolved quickly, as we found
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discontinued, PaO2 (87 ± 9 mmHg) was relatively close
to normal levels. At least in one study investigating
humans with acute respiratory failure [20], the loss of
functional lung volume that occurred as a result of ven-
tilation with 100% oxygen for 20 min, was immediately
reversible in 19 of 20 patients. In our study, butorphanol
was administered at the end of the recumbent period in
the rhinoceros that received oxygen as sole support, so it
is also likely that the butorphanol, together with stimula-
tion and getting the animal’s into a standing position,
led to improved ventilation and PaO2 values in these
animals. On the other hand, rhinoceros that were given
butorphanol at the beginning of the immobilization
period, and were only stimulated to stand after 25 min,
were still severely hypoxaemic (PaO2 = 58.4 ± 9.1 mmHg)
in the standing position. This finding reveals that opioid-
induced respiratory depression is a bigger complication
than recumbency during white rhinoceros immobilization.
The partial pressure of arterial oxygen during oxygen
administration may increase to a level at which hyper-
oxia occurs, thus affecting the ventilatory control system
by reducing the output of peripheral and central chemo-
receptors [24]. However, in our study, the rhinoceros
that received inhalation oxygen as the sole support never
became hyperoxic, but rather remained severely hypox-
aemic. Normally, increasing levels of hypercapnia, as ob-
served in these rhinoceros, should stimulate ventilation.
However, full opioid agonists, such as etorphine, signifi-
cantly reduce chemoreceptor sensitivity and therefore nor-
mal ventilatory control is inhibited during opioid-induced
immobilization [13]. This inhibition of ventilatory control
however, does not explain why the respiratory rate in
rhinoceros receiving oxygen decreased from about 8
breaths per minute before oxygen administration to about
3 breaths per minute at 15 min when PaCO2 was at its
highest (123 ± 12 mmHg) and PaO2 was only 44 ±
12 mmHg. Reasons for this further decrease in respiratory
rate are not clear, but we hypothesize that it was directly
related to the extreme hypercapnia resulting from a high
shunt fraction, which caused a central depression of
respiration [25].
This study has demonstrated that it is possible to
fully correct the severe hypoxaemia that occurs in
chemically-immobilized white rhinoceros. This is essen-
tial since inadequate tissue oxygenation may lead to an
acute cessation of organ function resulting in morbidity,
and even mortality [24]. However, although we managed
to correct the hypoxaemia using butorphanol + oxygen,
the intervention did not correct hypercapnia and acidae-
mia. Therefore, further investigations are needed to find
treatments that fully support the respiratory physiology
of immobilized white rhinoceros. Moreover, it is import-
ant to determine whether butorphanol combined withoxygen insufflation has the same positive effect on
immobilization-induced hypoxaemia in field-immobilized
white rhinoceros where increased exertion and other
variables may alter individual responses.
Conclusions
We compared the efficacy of butorphanol and oxygen
insufflation, alone or in combination, for reversing
opioid-induced respiratory depression in the chemically
immobilized white rhinoceros. Butorphanol alone, al-
though partly effective, did not prevent hypoxaemia and
hypercapnia. Oxygen insufflation also did not reverse
hypoxaemia or hypercapnia. Indeed, oxygen alone severely
compromised the animal’s respiratory status, an effect we
attribute to ventilation-perfusion mismatch and atelectasis.
Whilst the effects of butorphanol and oxygen adminis-
tered alone were disappointing, oxygen insufflation
combined with the intravenous administration of butor-
phanol at the beginning of the immobilization period
completely reversed hypoxaemia. This supportive inter-
vention therefore is likely to reduce, or even eliminate,
the risk of hypoxic damage to vital organs and muscles,
thereby improving the safety of white rhinoceros
immobilization. Rhinoceros that received this treat-
ment could be aroused with some stimulation, so that
they could be guided into a loading crate, an important
consideration when capturing large pachyderms. In the
confined boma setting, where rhinoceros can be darted
with ease and without excessive animal exertion, we
recommend butorphanol and oxygen as the best available
treatment to reverse hypoxaemia after etorphine adminis-
tration. Whether the butorphanol and oxygen combin-
ation is equally effective in field-immobilized rhinoceros
remains to be determined.
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